» Articles » PMID: 7869196

Long-term Effects of L-thyroxine Therapy for Congenital Hypothyroidism

Overview
Journal J Pediatr
Specialty Pediatrics
Date 1995 Mar 1
PMID 7869196
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To study the effects of initial and concurrent dose levels of L-thyroxine on ability and behavior in children with congenital hypothyroidism.

Methods: An existing database, involving a large cohort of children with congenital hypothyroidism detected by neonatal screening, was analyzed retrospectively. There were 94 children: 89 were assessed at age 7 years for intelligence and selective cognitive abilities, and 87 at age 8 years for behavior, achievement, and selective abilities.

Results: Subjects were stratified by median split into low and high starting dose groups. The high-dose group performed better on indexes of intelligence, verbal ability, and memory but had more behavior problems reflecting increased anxiety, social withdrawal, and poorer concentration. The dose of L-thyroxine at age 8 years was negatively correlated with memory task performance.

Conclusion: A higher starting dose of L-thyroxine is beneficial for subsequent intellectual outcome in children with congenital hypothyroidism but may be associated with internalizing behavior problems.

Citing Articles

Congenital hypothyroidism and associated visual-motor and intellectual development.

Ontiveros-Mendoza E, Gonzalez-Medrano J, Rivera-Gonzalez R, Sanchez-Huerta K, Sanchez C, Barragan-Mejia G Pediatr Res. 2025; .

PMID: 39843775 DOI: 10.1038/s41390-025-03850-3.


Higher initial levothyroxine doses and very early treatment start may lead to better cognitive outcomes in children with congenital hypothyroidism.

Danner E, Niuro L, Lapinoja S, Huopio H, Viikari L, Kero J Acta Paediatr. 2024; 114(3):594-602.

PMID: 39487608 PMC: 11828728. DOI: 10.1111/apa.17479.


Guidelines for Newborn Screening of Congenital Hypothyroidism (2021 Revision).

Nagasaki K, Minamitani K, Nakamura A, Kobayashi H, Numakura C, Itoh M Clin Pediatr Endocrinol. 2023; 32(1):26-51.

PMID: 36761493 PMC: 9887297. DOI: 10.1297/cpe.2022-0063.


An Overview on Different L-Thyroxine (l-T) Formulations and Factors Potentially Influencing the Treatment of Congenital Hypothyroidism During the First 3 Years of Life.

Stagi S, Municchi G, Ferrari M, Wasniewska M Front Endocrinol (Lausanne). 2022; 13:859487.

PMID: 35757415 PMC: 9218053. DOI: 10.3389/fendo.2022.859487.


Neuropsychological Alterations in Patients with Congenital Hypothyroidism Treated with Levothyroxine: Linked Factors and Thyroid Hormone Hyposensitivity.

Razon-Hernandez K, Osnaya-Brizuela N, Valenzuela-Peraza A, Ontiveros-Mendoza E, Rodriguez-Serrano L, Pacheco-Rosado J J Clin Med. 2022; 11(12).

PMID: 35743497 PMC: 9224966. DOI: 10.3390/jcm11123427.